VRTX Operating Expenses

Vertex Pharmaceuticals · Operating Expenses

VRTX logo

VRTX Operating Expenses

Latest reported$5.99B
VRTX Operating Expenses ($6.40M → $5.99B)
High-resolution chart · PNG

VRTX operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
5,506,800,000
9,722,500,000
4,775,000,000
3,543,000,000
3,891,200,000
2,613,100,000
2,413,038,000
1,974,092,000
1,820,704,000
1,480,519,000
1,373,250,000
1,160,915,000
1,281,125,000
1,242,981,000
1,108,427,000
825,216,000
679,982,000
618,202,000
597,781,000
429,573,000
292,530,000
234,301,000
238,718,000
252,408,000
196,010,000
112,727,000
104,600,000
81,300,000
66,600,000
46,300,000
52,300,000
43,800,000
30,600,000
16,600,000
10,600,000
6,400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.